Who Should Stay on GLP-1 Compounds Long-Term: Safety and Clinical Considerations GLP-1 compounds are indicated for patients with obesity or overweight with comorbidities
In these specific cases the first study is selecting a subject cohort based on a diagnosis of diabetes mellitus type 2 (DMT2) and the second obesity
Were here to replace it
Using PF injectables ensures you get the maximum benefit with the minimum of additional excipients in your IV mixture
Using chemogenetic, optogenetic, and viral tracing strategies to study how GLP-1 signals in the brain impact liver fibrosis and inflammation is an area of intense basic investigation
Last reviewed: June 19, 2026 Last updated: June 19, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations